The global impact of the COVID-19 pandemic on the management and course of chronic urticaria
ALLERGY, cilt.76, sa.3, ss.816-830, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 76 Sayı: 3
- Basım Tarihi: 2021
- Doi Numarası: 10.1111/all.14687
- Dergi Adı: ALLERGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, Food Science & Technology Abstracts, MEDLINE, Veterinary Science Database
- Sayfa Sayıları: ss.816-830
- Anahtar Kelimeler: chronic urticaria, COVID-19, cyclosporine, omalizumab, pandemic, SARS-CoV-2, treatment, UCARE, ASSOCIATION, INFECTIONS, OMALIZUMAB, STRESS, SERUM
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- İstanbul Üniversitesi Adresli: Evet
Özet
Introduction The COVID-19 pandemic dramatically disrupts health care around the globe. The impact of the pandemic on chronic urticaria (CU) and its management are largely unknown.